Location History:
- Malmo, SE (1993)
- Malmö, SE (2005 - 2008)
Company Filing History:
1 out of 789 
1 out of 1 
1 out of 23 Years Active: 1993-2008
Title: Innovations of Johan Stenflo
Introduction
Johan Stenflo is a notable inventor based in Malmö, Sweden. He has made significant contributions to the field of biochemistry, particularly in the development of antibodies for medical applications. With a total of 3 patents, his work has advanced the understanding and detection of specific proteins in biological systems.
Latest Patents
Stenflo's latest patents include innovative antibodies that bind to gamma carboxyglutamic acid (Gla). These antibodies are designed to identify Gla residues in proteins and peptides without reacting with glutamic acid residues. The patents also describe methods for preparing and identifying these antibodies, as well as their application in detecting Gla in biological fluids and tissues. Another significant patent involves a monoclonal antibody that monitors the activity of systems involving protein C inhibitor. This invention is crucial for diagnosing conditions such as venous thrombosis, showcasing the antibody's specific affinity for both the complexed and uncomplexed forms of the inhibitor.
Career Highlights
Throughout his career, Johan Stenflo has worked with prominent companies in the biotechnology sector, including Genzyme Corporation and Protease Ab. His experience in these organizations has contributed to his expertise in antibody development and biochemistry.
Collaborations
Stenflo has collaborated with notable professionals in his field, including Robert Wydro and Edward Cohen. These partnerships have likely enhanced his research and innovation capabilities.
Conclusion
Johan Stenflo's contributions to the field of biochemistry through his patents and collaborations highlight his role as a significant inventor. His work continues to impact medical diagnostics and therapeutic developments.